Keensight Capital to acquire Inke from Neuraxpharm
Inke is an inhalation active pharmaceutical ingredients (APIs) developer and manufacturer.
Inke is an inhalation active pharmaceutical ingredients (APIs) developer and manufacturer.
Copyright PEI Media
Not for publication, email or dissemination
